|
|
| (One intermediate revision by one other user not shown) |
| Line 1: |
Line 1: |
| The overall poor prognosis of stent thrombosis makes this rare complication, a devastating and hence extremely inportant one. A sub-analysis of TRITON-TIMI 38 study showed that stent thrombosis was associated with death or myocardial infarction in 89% (186/210) of patients<ref name="pmid18377975">{{cite journal |author=Wiviott SD, Braunwald E, McCabe CH, ''et al.'' |title=Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial |journal=Lancet |volume=371 |issue=9621 |pages=1353–63 |year=2008 |month=April |pmid=18377975 |doi=10.1016/S0140-6736(08)60422-5 |url=}}</ref>. In follow up studies after stent thrombosis, recurrent stent thrombosis has also been noticed, especially during the following six months<ref name="pmid19232197">{{cite journal |author=Gallego L, Martínez-Sellés M, García E, ''et al.'' |title=Characteristics and outcome of angiographically confirmed stent thrombosis |journal=Rev Esp Cardiol |volume=62 |issue=2 |pages=220–3 |year=2009 |month=February |pmid=19232197 |doi= |url=}}</ref>.
| |
|
| |
|
|
| |
|
| |
| ==References==
| |
| {{reflist|2}}
| |